Skip to main content Skip to main navigation menu Skip to site footer

Gambaran hasil pemeriksaan faal hemostasis pada penderita Diabetes Melitus tipe-2 (DM-2) di RSUP Sanglah, Bali, Indonesia


Background: Diabetes Mellitus Type II (DM-2) is a type of hyperglycemic state which is related to metabolic disorders caused by mutations in several genes. Faal hemostasis is a function of the body that aims to maintain the blood that has been thinned so that the blood flowing in the veins and could be interfere with blood glucose level. This study aims to describe the faal hemostasis examination in patients with DM-2 in Sanglah Hospital.

Methods: A cross-sectional study was conducted among patients with diabetes mellitus type II (DM-2) who were hospitalized in Sanglah hospital at the period started from January 1st to December 31st, 2015. The sample selection were using consecutive sampling with a total of twenty eight samples. Data were analyzed using SPSS version 17 for Windows

Results: The study found that males were predominant in this study (53.6%). In addition, 51-60 years age group were also predominant (39.3%), following by history of hypertension (82.1%), 10-14 seconds of Prothrombin Time (PT) (67.9%), 30-40 seconds of Activated Partial Thromboplastin Time (APTT) (53.5%), and bleeding time (BT) > 1.3 minutes (67.9%).

Conclusion: Several faal hemostasis assessments were predominant in patients with DM-2 such as 10-14 seconds of PT, 20-40 seconds of APTT, and bleeding time more than 1.3 minutes.


  1. Barclay A, Gilbertson H, Marsh K, Smart C. Dietary management in diabetes. Aust Fam Physician. 2010; 39(8):579-83.
  2. Kharroubi AT, Darwish HM. Diabetes mellitus: The epidemic of the century. World J Diabetes. 2015 Jun 25;6(6):850-67
  3. Forouhi NG, Wareham NJ. Epidemiology of diabetes. Medicine (Abingdon). 2014; 42(12): 698–702.
  4. Mihardja L, Soetrisno U, Soegondo S. Prevalence and clinical profile of diabetes mellitus in productive aged urban Indonesians. J Diabetes Investig. 2014;5(5):507-12.
  5. Garry-Webb TL, Suglia SF, Tehranifar P. Social Epidemiology of Diabetes and Associated Conditions. Curr Diab Rep. 2013; 13(6):850–859.
  6. Tapp RJ, Shaw JE, Harper CA et al. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care. 2003 ;26(6):1731-7.
  7. Carr ME. Diabetes mellitus: a hypercoagulable state. J Diabetes Complications. 2001 ;15(1):44-54.
  8. Awad N, Langi YA, Pandelaki K. Gambaran faktor resiko pasien diabetes melitus tipe II di poliklinik endokrin Bagian/SMF FK-Unsrat RSU Prof. Dr. R.D Kandou Manado Periode Mei 2011 - Oktober 2011. Jurnal e-Biomedik (eBM). 2013; 1(1):45-49.
  9. Langi YA. Penatalaksanaan ulkus kaki diabetes secara terpadu. Jurnal Biomedik. 2011; 3(2):95-101
  10. Mayangsari E, Octaviana EW, Farihatun A. Gambaran hasil pemeriksaan bleeding time (waktu perdarahan) dengan metode IVY dan DUKE. Jurnal Stikes Muhammadiyah Ciamis. [Skripsi]. 2016: 1-24

How to Cite

Pramudita, N., & Mulyantari, N. K. (2019). Gambaran hasil pemeriksaan faal hemostasis pada penderita Diabetes Melitus tipe-2 (DM-2) di RSUP Sanglah, Bali, Indonesia. Intisari Sains Medis, 10(2).




Search Panel

Nyoman Pramudita
Google Scholar
ISM Journal

Ni Kadek Mulyantari
Google Scholar
ISM Journal